These results indicate that cPLA2α mediates TGF-β-induced EMT in human breast cancer cells via the PI3K/Akt/GSK-3β/β-catenin signaling pathway, ultimately improving their invasive and migratory potential. The gene discussed is AKT1; the disease is breast carcinoma.